Science
FDA Clears First Blood Test for Diagnosing Alzheimer’s
Alzheimer’s disease, the most common form of dementia, affects more than 6 million Americans and over 55 million people worldwide. Until now, diagnosing Alzheimer’s has been a complex and often invasive process, requiring expensive PET scans or lumbar punctures (spinal taps) to detect biomarkers in cerebrospinal fluid (CSF). However, in a landmark decision, the U.S. Food and Drug Administration (FDA) has cleared the first blood test to aid in diagnosing Alzheimer’s disease—a move that could revolutionize early detection and treatment.
By World Mirror10 months ago in Chapters
After the stars fell
Write a story after the happily ever after I often wondered what love is. Is it truly the warm, fuzzy emotions that ooze out of true mirth of care and adore, or is it a product of prevalent capitalism that exists within our world? That makes it easy for the consumeristic and hyperagile construct to sell products to the humans as a marketing tactic, to slip in through the psyche of innocent minds, to create a buzz, to find their weaklings and exploit them for company profits and expansions. I still find myself wondering what love is, pondering over that thought.
By Hridya Sharma10 months ago in Chapters










